- Home
- OGEN vs BMRA Comparison
OGEN vs BMRA Comparison
Compare OGEN & BMRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OGEN
- BMRA
- Stock Information
- Founded
- OGEN 1996
- BMRA 1971
- Country
- OGEN United States
- BMRA United States
- Employees
- OGEN N/A
- BMRA N/A
- Industry
- OGEN Biotechnology: Pharmaceutical Preparations
- BMRA Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- OGEN Health Care
- BMRA Health Care
- Exchange
- OGEN Nasdaq
- BMRA Nasdaq
- Market Cap
- OGEN 2.5M
- BMRA 8.1M
- IPO Year
- OGEN N/A
- BMRA N/A
- Fundamental
- Price
- OGEN $3.83
- BMRA $3.09
- Analyst Decision
- OGEN
- BMRA
- Analyst Count
- OGEN 0
- BMRA 0
- Target Price
- OGEN N/A
- BMRA N/A
- AVG Volume (30 Days)
- OGEN 655.3K
- BMRA 26.1K
- Earning Date
- OGEN 08-08-2025
- BMRA 04-14-2025
- Dividend Yield
- OGEN N/A
- BMRA N/A
- EPS Growth
- OGEN N/A
- BMRA N/A
- EPS
- OGEN N/A
- BMRA N/A
- Revenue
- OGEN N/A
- BMRA $5,678,000.00
- Revenue This Year
- OGEN N/A
- BMRA N/A
- Revenue Next Year
- OGEN N/A
- BMRA N/A
- P/E Ratio
- OGEN N/A
- BMRA N/A
- Revenue Growth
- OGEN N/A
- BMRA 5.01
- 52 Week Low
- OGEN $3.12
- BMRA $1.93
- 52 Week High
- OGEN $75.60
- BMRA $10.16
- Technical
- Relative Strength Index (RSI)
- OGEN 47.04
- BMRA 45.39
- Support Level
- OGEN $3.41
- BMRA $3.03
- Resistance Level
- OGEN $4.85
- BMRA $3.44
- Average True Range (ATR)
- OGEN 0.58
- BMRA 0.19
- MACD
- OGEN 0.01
- BMRA 0.01
- Stochastic Oscillator
- OGEN 42.49
- BMRA 43.24
About OGEN Oragenics Inc.
Oragenics Inc is engaged in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases. The company's product ONP-002 is a fully synthetic, non-naturally occurring neurosteroid, is lipophilic, and can cross the blood-brain barrier to rapidly reduce swelling, oxidative stress and inflammation while restoring proper blood flow through gene amplification. The Company operates in one reportable segment, which includes activities related to advancing the development of its concussion drug, ONP-002.
About BMRA Biomerica Inc.
Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.